The Global Dementia Treatment Market is poised for substantial growth, estimated at USD 16.69 billion in 2023 and projected to expand at a compound annual growth rate (CAGR) of 8.0% over the forecast period 2024-2032. The rapid expansion is largely driven by high disease prevalence, an aging global population, and increasing research and development (R&D) initiatives focused on novel therapeutic solutions. As the burden of dementia continues to rise, governments and healthcare organizations worldwide are ramping up efforts to enhance diagnosis, treatment accessibility, and patient awareness programs.
In 2023, over 55 million people worldwide were diagnosed with dementia, with projections indicating an increase to 78 million by 2030 and 139 million by 2050, according to the World Health Organization (WHO). The introduction of innovative pharmaceutical therapies and government-backed funding for clinical research have further bolstered market expansion. For instance, in July 2023, the U.S. Food and Drug Administration (FDA) granted approval for Leqembi (lecanemab), an Alzheimer’s treatment developed by Eisai Co., Ltd., to help slow cognitive decline. Similarly, government initiatives such as the U.S. Department of Health & Human Services' (HHS) roadmap for dementia care, unveiled in December 2023, emphasize research support and treatment accessibility.
The development of next-generation therapies, such as anti-amyloid antibodies, is emerging as a transformative trend within the dementia treatment market. Lecanemab and donanemab, two promising drug candidates, have demonstrated 27% and 35% reductions in cognitive decline, respectively, after 18 months of treatment. Furthermore, a robust pipeline of phase 1, phase 2, and phase 3 clinical trials continues to drive optimism among pharmaceutical developers and investors.
From a regional perspective, North America dominated the global market in 2023, accounting for 37.6% of the total revenue. This dominance is attributed to a high disease burden, strong presence of key market players, and well-established healthcare infrastructure. Europe follows closely, with countries like Germany, France, and the UK investing heavily in dementia research. Meanwhile, the Asia-Pacific region is anticipated to witness the fastest CAGR of 9.5%, fueled by expanding healthcare facilities, increasing awareness programs, and a growing elderly population.
Major Market Players Included in This Report:
• Eisai Co., Ltd.
• Eli Lilly and Company
• Novartis AG
• Daiichi Sankyo Company, Limited
• AbbVie Inc.
• Lundbeck
• Biogen
• Cipla
• Sun Pharmaceutical Industries Ltd.
• Viatris Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Amneal Pharmaceuticals LLC
• Cognition Therapeutics, Inc.
• Corium, Inc.
• Alpha Cognition Inc.
The Detailed Segments and Sub-Segment of the Market Are Explained Below:
By Indication
• Alzheimer’s Disease Dementia
• Vascular Dementia
• Lewy Body Dementia
• Frontotemporal Dementia (FTD)
• Parkinson Disease Dementia
• Others
By Drug Class
• Cholinesterase Inhibitors
• NMDA Receptor Antagonists
• MAO Inhibitors
• Combination Drug
• Others
By Route of Administration
• Oral
• Transdermal Patch
• Injectable
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Years Considered for the Study:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years (2022-2032)
• Annualized Revenue and Regional-Level Analysis for each market segment
• Geographical Breakdown with country-level market evaluations
• Competitive Landscape Analysis with information on major market players
• Insights into Key Business Strategies and recommendations for market entry and growth
• Supply & Demand Side Analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- Chapter 1. Global Dementia Treatment Market Executive Summary
- 1.1. Global Dementia Treatment Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Indication
- 1.3.2. By Drug Class
- 1.3.3. By Route of Administration
- 1.3.4. By Distribution Channel
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Dementia Treatment Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Dementia Treatment Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rising Geriatric Population
- 3.1.2. Increasing Prevalence of Dementia
- 3.1.3. Advancements in Drug Discovery & Approvals
- 3.2. Market Challenges
- 3.2.1. High Costs of Dementia Medications
- 3.2.2. Complexity in Clinical Trials & Drug Development
- 3.3. Market Opportunities
- 3.3.1. Government Initiatives & Funding
- 3.3.2. Expansion of Telemedicine & Online Pharmacies
- Chapter 4. Global Dementia Treatment Market Industry Analysis
- 4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
- 4.1.7. Porter’s 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Dementia Treatment Market Size & Forecasts by Indication (2022-2032)
- 5.1. Segment Dashboard
- 5.2. Global Dementia Treatment Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Alzheimer’s Disease Dementia
- 5.2.2. Vascular Dementia
- 5.2.3. Lewy Body Dementia
- 5.2.4. Frontotemporal Dementia
- 5.2.5. Parkinson Disease Dementia
- 5.2.6. Others
- Chapter 6. Global Dementia Treatment Market Size & Forecasts by Drug Class (2022-2032)
- 6.1. Segment Dashboard
- 6.2. Global Dementia Treatment Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Cholinesterase Inhibitors
- 6.2.2. NMDA Receptor Antagonists
- 6.2.3. MAO Inhibitors
- 6.2.4. Combination Drug
- 6.2.5. Others
- Chapter 7. Global Dementia Treatment Market Size & Forecasts by Route of Administration (2022-2032)
- 7.1. Segment Dashboard
- 7.2. Global Dementia Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Oral
- 7.2.2. Transdermal Patch
- 7.2.3. Injectable
- Chapter 8. Global Dementia Treatment Market Size & Forecasts by Distribution Channel (2022-2032)
- 8.1. Segment Dashboard
- 8.2. Global Dementia Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Hospital Pharmacy
- 8.2.2. Retail Pharmacy
- 8.2.3. Online Pharmacy
- Chapter 9. Global Dementia Treatment Market Size & Forecasts by Region (2022-2032)
- 9.1. North America Dementia Treatment Market
- 9.1.1. U.S. Dementia Treatment Market
- 9.1.2. Canada Dementia Treatment Market
- 9.2. Europe Dementia Treatment Market
- 9.2.1. U.K. Dementia Treatment Market
- 9.2.2. Germany Dementia Treatment Market
- 9.2.3. France Dementia Treatment Market
- 9.2.4. Spain Dementia Treatment Market
- 9.2.5. Italy Dementia Treatment Market
- 9.2.6. Rest of Europe Dementia Treatment Market
- 9.3. Asia-Pacific Dementia Treatment Market
- 9.3.1. China Dementia Treatment Market
- 9.3.2. India Dementia Treatment Market
- 9.3.3. Japan Dementia Treatment Market
- 9.3.4. Australia Dementia Treatment Market
- 9.3.5. South Korea Dementia Treatment Market
- 9.3.6. Rest of Asia Pacific Dementia Treatment Market
- 9.4. Latin America Dementia Treatment Market
- 9.4.1. Brazil Dementia Treatment Market
- 9.4.2. Mexico Dementia Treatment Market
- 9.4.3. Rest of Latin America Dementia Treatment Market
- 9.5. Middle East & Africa Dementia Treatment Market
- 9.5.1. Saudi Arabia Dementia Treatment Market
- 9.5.2. South Africa Dementia Treatment Market
- 9.5.3. Rest of Middle East & Africa Dementia Treatment Market
- Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. Eisai Co., Ltd.
- 10.1.2. Eli Lilly and Company
- 10.1.3. Biogen
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- List of Tables
- 1. Global Dementia Treatment Market, Report Scope
- 2. Global Dementia Treatment Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
- 3. Global Dementia Treatment Market Estimates & Forecasts by Indication 2022-2032 (USD Billion)
- 4. Global Dementia Treatment Market Estimates & Forecasts by Drug Class 2022-2032 (USD Billion)
- 5. Global Dementia Treatment Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
- 6. Global Dementia Treatment Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
- 7. Regional Breakdown of Dementia Prevalence (2022-2032) (Million People)
- 8. Government Initiatives for Dementia Awareness and Treatment (2022-2032)
- 9. Key Investments in Dementia Drug Development by Region (2022-2032) (USD Billion)
- 10. Top 10 Dementia Treatment Drugs by Revenue (2022-2032) (USD Million/Billion)
- 11. Comparison of Approved Dementia Drugs by Effectiveness and Safety (2022-2032)
- 12. Pipeline Analysis of Dementia Drugs (Phase 1, 2, and 3 Trials) (2022-2032)
- 13. Market Share of Leading Dementia Drug Manufacturers (2022-2032) (%)
- 14. Adoption Rate of Oral vs. Injectable Dementia Medications by Region (2022-2032)
- 15. Impact of AI & Digital Health Technologies in Dementia Treatment (2022-2032)
- 16. Reimbursement Policies for Dementia Drugs in Major Countries (2022-2032)
- 17. Growth Analysis of Online Pharmacies for Dementia Drug Sales (2022-2032) (%)
- 18. Prevalence of Alzheimer’s Disease Dementia vs. Other Dementia Types (2022-2032) (%)
- 19. Key Mergers & Acquisitions in the Dementia Treatment Market (2022-2032)
- 20. Research & Development Spending by Major Players (2022-2032) (USD Billion)
- (This list is not complete, the final report contains more than 100 tables. The list may be updated in the final deliverable.)
- List of Figures
- 1. Global Dementia Treatment Market, Research Methodology
- 2. Global Dementia Treatment Market, Market Estimation Techniques
- 3. Dementia Prevalence by Age Group (2022-2032) (%)
- 4. Dementia Cases per 100,000 People by Region (2022-2032)
- 5. Growth Prospects of the Dementia Treatment Market (2022-2032) (USD Billion)
- 6. Porter’s Five Forces Analysis of the Dementia Treatment Industry
- 7. PESTEL Analysis of the Dementia Treatment Market
- 8. Global Dementia Drug Market by Type (Cholinesterase Inhibitors, NMDA Antagonists, Others) (2022-2032) (%)
- 9. Breakdown of Dementia Drug Market by Route of Administration (2022-2032) (%)
- 10. Comparison of Market Share of Dementia Drugs in North America, Europe, APAC, and LATAM (2022-2032) (%)
- 11. Dementia Drug Approvals in the Last Five Years (2020-2025)
- 12. Revenue Forecast for Major Players in the Dementia Treatment Market (2022-2032) (USD Billion)
- 13. Number of Clinical Trials for Dementia Drugs by Phase (2022-2032)
- 14. Projected Demand for New Dementia Treatment Solutions (2022-2032) (USD Billion)
- 15. Dementia Treatment Costs by Region (2022-2032) (USD Million/Billion)
- 16. Breakdown of Hospital Pharmacy vs. Retail Pharmacy Sales for Dementia Drugs (2022-2032) (%)
- 17. Geographic Expansion Strategies of Major Dementia Drug Manufacturers (2022-2032)
- 18. Key Strategic Alliances in the Dementia Drug Industry (2022-2032)
- 19. Impact of AI & Machine Learning in Dementia Diagnosis & Treatment (2022-2032)
- 20. Regulatory Approvals Timeline for Dementia Drugs in Key Markets (2022-2032)
- (This list is not complete, the final report contains more than 50 figures. The list may be updated in the final deliverable.) "
- "• 3M Company
- • Ivoclar Vivadent AG
- • GC Corporation
- • Envista Holdings Corporation
- • Henry Schein, Inc.
- • Kuraray Co., Ltd.
- • Mitsui Chemicals, Inc.
- • Dentsply Sirona
- • Brasseler USA
- • Geistlich Pharma AG
- • Kettenbach GmbH & Co. KG
- • DMG Chemisch-Pharmazeutische Fabrik GmbH
- • J. Morita Corp.
- • BEGO GmbH & Co. KG
- • Coltène/Whaledent AG
- List of Tables
- 1. Global Dental Fillings Market, Report Scope
- 2. Global Dental Fillings Market Estimates & Forecasts by Region (2022-2032) (USD Billion)
- 3. Global Dental Fillings Market Estimates & Forecasts by Type (2022-2032) (USD Billion)
- 4. Global Dental Fillings Market Estimates & Forecasts by Material (2022-2032) (USD Billion)
- 5. Global Dental Fillings Market Estimates & Forecasts by End-User (2022-2032) (USD Billion)
- 6. North America Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 7. U.S. Dental Fillings Market Estimates & Forecasts by Type (2022-2032) (USD Billion)
- 8. U.S. Dental Fillings Market Estimates & Forecasts by Material (2022-2032) (USD Billion)
- 9. U.S. Dental Fillings Market Estimates & Forecasts by End-User (2022-2032) (USD Billion)
- 10. Canada Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 11. Europe Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 12. Germany Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 13. France Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 14. UK Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 15. Italy Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 16. Spain Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 17. Asia-Pacific Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 18. China Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 19. Japan Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 20. India Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 21. Latin America Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 22. Brazil Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 23. Argentina Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 24. Middle East & Africa Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 25. Saudi Arabia Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 26. UAE Dental Fillings Market Estimates & Forecasts (2022-2032) (USD Billion)
- 27. Top Companies Market Share in Global Dental Fillings Market (2023-2032) (%)
- 28. Mergers, Acquisitions, and Collaborations in the Dental Fillings Industry (2020-2032)
- 29. Investment Trends and Funding in Dental Fillings Market (2020-2032) (USD Million)
- This list is not complete, the final report contains more than 100 tables. The list may be updated in the final deliverable.
- List of Figures
- 1. Global Dental Fillings Market, Research Methodology
- 2. Global Dental Fillings Market, Market Estimation Techniques
- 3. Global Market Size Estimates & Forecast Methods
- 4. Global Dental Fillings Market, Key Trends (2022-2032)
- 5. Global Dental Fillings Market, Growth Prospects (2022-2032)
- 6. Global Dental Fillings Market, Porter’s Five Force Model
- 7. Global Dental Fillings Market, PESTEL Analysis
- 8. Global Dental Fillings Market, Value Chain Analysis
- 9. Global Dental Fillings Market by Type (2022 & 2032) (USD Billion)
- 10. Global Dental Fillings Market by Material (2022 & 2032) (USD Billion)
- 11. Global Dental Fillings Market by End-User (2022 & 2032) (USD Billion)
- 12. North America Dental Fillings Market Growth Trends (2022-2032)
- 13. Europe Dental Fillings Market Growth Trends (2022-2032)
- 14. Asia Pacific Dental Fillings Market Growth Trends (2022-2032)
- 15. Latin America Dental Fillings Market Growth Trends (2022-2032)
- 16. Middle East & Africa Dental Fillings Market Growth Trends (2022-2032)
- 17. Market Share of Top Players in Global Dental Fillings Market (2023-2032) (%)
- 18. Investment Trends in Dental Fillings Market by Region (2022-2032) (USD Billion)
- 19. Innovations in Bioactive and Nanotechnology-Infused Dental Fillings (2022-2032)
- 20. Key Developments in Regulatory Approvals for Dental Fillings (2022-2032)
- 21. Impact of Dental Tourism on Dental Fillings Market (2022-2032) (USD Billion)
- 22. R&D Investments in Advanced Dental Filling Materials (2022-2032) (USD Million)
- 23. Distribution Channels Analysis in Global Dental Fillings Market (2022-2032)
- 24. Comparative Cost Analysis of Different Dental Filling Materials (2022-2032) (USD Per Unit)
- 25. Technological Advancements in Dental Restoration Techniques (2022-2032)
- This list is not complete, the final report contains more than 50 figures. The list may be updated in the final deliverable.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook